Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria F Becerra

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BJUI Compass|August 28, 2023
Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imagingRicardo de Almeida S, Jamie Thomas, Matthew M Mason, et al.
Urologic Oncology|April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomyDaniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.
Urologic Oncology|September 9, 2020
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohortRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Urologic Oncology|September 28, 2021
Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysisRoy Mano, Cihan Duzgol, Maz Ganat, et al.
European Urology Focus|September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell CarcinomaJozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
The Journal of Urology|April 10, 2020
Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical CystectomyMaria F Becerra, Vivek Venkatramani, Isildinha M Reis, et al.
European Urology Focus|July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell CarcinomaBrandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
The Journal of Urology|September 25, 2019
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year FollowupVivek Venkatramani, Isildinha M Reis, Erik P Castle, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BJUI Compass|August 28, 2023
Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imagingRicardo de Almeida S, Jamie Thomas, Matthew M Mason, et al.
Urologic Oncology|April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomyDaniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.
Urologic Oncology|September 9, 2020
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohortRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Urologic Oncology|September 28, 2021
Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysisRoy Mano, Cihan Duzgol, Maz Ganat, et al.
European Urology Focus|September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell CarcinomaJozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
The Journal of Urology|April 10, 2020
Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical CystectomyMaria F Becerra, Vivek Venkatramani, Isildinha M Reis, et al.
European Urology Focus|July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell CarcinomaBrandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
The Journal of Urology|September 25, 2019
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year FollowupVivek Venkatramani, Isildinha M Reis, Erik P Castle, et al.
Pageof 4